No Cover Image

Journal article 336 views 164 downloads

Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus

Samuel Seidu, Lorraine Avery, Heather Bell, Pam Brown, Jane Diggle, Su Down, Ritesh Dua, Patrick Holmes Orcid Logo, Rahul Mohan, Nicola Milne, Thinzar Min Orcid Logo, James Ridgeway, Waqas Tahir, Sanjay Tanna

Diabetic Medicine, Volume: 42, Issue: 3

Swansea University Author: Thinzar Min Orcid Logo

  • 69258.VoR.pdf

    PDF | Version of Record

    © 2024 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License.

    Download (261.44KB)

Check full text

DOI (Published version): 10.1111/dme.15500

Abstract

AimsThis expert consensus reviews the reality of primary care clinical management of people with type 2 diabetes (T2D) on non-intensive insulin therapy, with an emphasis on the use of continuous glucose monitoring (CGM) technology for effective care in this participant group. Here, we identify key u...

Full description

Published in: Diabetic Medicine
ISSN: 0742-3071 1464-5491
Published: Wiley 2025
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa69258
first_indexed 2025-04-10T16:01:51Z
last_indexed 2025-05-13T09:11:02Z
id cronfa69258
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2025-05-12T13:52:38.9283080</datestamp><bib-version>v2</bib-version><id>69258</id><entry>2025-04-10</entry><title>Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus</title><swanseaauthors><author><sid>27cba511a4800fefddb6885ffffdb8b2</sid><ORCID>0000-0003-4467-3840</ORCID><firstname>Thinzar</firstname><surname>Min</surname><name>Thinzar Min</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2025-04-10</date><deptcode>MEDS</deptcode><abstract>AimsThis expert consensus reviews the reality of primary care clinical management of people with type 2 diabetes (T2D) on non-intensive insulin therapy, with an emphasis on the use of continuous glucose monitoring (CGM) technology for effective care in this participant group. Here, we identify key unmet needs for skills and systems development within this frontline healthcare setting, along with major challenges and opportunities associated with managing these changes effectively.MethodsThe authors participated in two primary care consensus panels held on 28 November 2023 and on 21 May 2024. The focus for these expert panels was to understand the unmet needs within primary care to manage adults with T2D treated with non-intensive insulin therapy and incorporating the use of CGM systems. A Delphi Survey was undertaken among a wider group of Primary Care Diabetes Technology Network members in the United Kingdom, to understand prevalent attitudes to management of adults with T2D on insulin and using CGM in primary care. Based on these activities, a series of consensus statements were tested in a second Delphi Survey.ResultsThe activities described, involving primary care healthcare professionals (HCPs) with expertise in diabetes management, identified a series of training and educational needs within UK general practice that are central to skills development for the care of adults with T2D on insulin therapy and the application of CGM technology. Potential barriers to effective primary care management of people with T2D using CGM devices were identified. Areas of concern included confidence in national and local guidelines for the management of T2D using CGM systems, lack of experience on the part both of HCPs and people with T2D, clinical workflows and systems, as well as inbuilt resistance to change among primary care teams. However, the expert group were clear that the goal of providing care for people with T2D on non-intensive insulin therapy using CGM technology as standard of care could be met (94.3%, n&#x2009;=&#x2009;33). This will deliver clinical benefits for people with T2D, and improvements to clinical workflows in primary care. Cost-savings to the health service were also identified as an outcome.ConclusionsThe need to adapt to the management of people with T2D on insulin therapy puts significant pressure on current workflows and skills for primary care teams. Steps in overcoming these immediate pressures, to ensure effective clinical management of people with T2D, are discussed, along with a series of consensus statements that identify the key areas of change to manage. Ultimately, the great majority of expert primary care HCPs were confident or very confident that using CGM technology will become the standard of care for people with T2D treated with insulin in primary care.</abstract><type>Journal Article</type><journal>Diabetic Medicine</journal><volume>42</volume><journalNumber>3</journalNumber><paginationStart/><paginationEnd/><publisher>Wiley</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0742-3071</issnPrint><issnElectronic>1464-5491</issnElectronic><keywords>continuous blood glucose monitoring; primary care; type 2 diabetes</keywords><publishedDay>1</publishedDay><publishedMonth>3</publishedMonth><publishedYear>2025</publishedYear><publishedDate>2025-03-01</publishedDate><doi>10.1111/dme.15500</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm>Another institution paid the OA fee</apcterm><funders/><projectreference/><lastEdited>2025-05-12T13:52:38.9283080</lastEdited><Created>2025-04-10T12:37:00.1034183</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Biomedical Science</level></path><authors><author><firstname>Samuel</firstname><surname>Seidu</surname><order>1</order></author><author><firstname>Lorraine</firstname><surname>Avery</surname><order>2</order></author><author><firstname>Heather</firstname><surname>Bell</surname><order>3</order></author><author><firstname>Pam</firstname><surname>Brown</surname><order>4</order></author><author><firstname>Jane</firstname><surname>Diggle</surname><order>5</order></author><author><firstname>Su</firstname><surname>Down</surname><order>6</order></author><author><firstname>Ritesh</firstname><surname>Dua</surname><order>7</order></author><author><firstname>Patrick</firstname><surname>Holmes</surname><orcid>0000-0002-6401-663x</orcid><order>8</order></author><author><firstname>Rahul</firstname><surname>Mohan</surname><order>9</order></author><author><firstname>Nicola</firstname><surname>Milne</surname><order>10</order></author><author><firstname>Thinzar</firstname><surname>Min</surname><orcid>0000-0003-4467-3840</orcid><order>11</order></author><author><firstname>James</firstname><surname>Ridgeway</surname><order>12</order></author><author><firstname>Waqas</firstname><surname>Tahir</surname><order>13</order></author><author><firstname>Sanjay</firstname><surname>Tanna</surname><order>14</order></author></authors><documents><document><filename>69258__34250__0d5e938e5b6348bc9038d26c2d5b4804.pdf</filename><originalFilename>69258.VoR.pdf</originalFilename><uploaded>2025-05-12T13:49:38.9354913</uploaded><type>Output</type><contentLength>267711</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>&#xA9; 2024 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2025-05-12T13:52:38.9283080 v2 69258 2025-04-10 Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus 27cba511a4800fefddb6885ffffdb8b2 0000-0003-4467-3840 Thinzar Min Thinzar Min true false 2025-04-10 MEDS AimsThis expert consensus reviews the reality of primary care clinical management of people with type 2 diabetes (T2D) on non-intensive insulin therapy, with an emphasis on the use of continuous glucose monitoring (CGM) technology for effective care in this participant group. Here, we identify key unmet needs for skills and systems development within this frontline healthcare setting, along with major challenges and opportunities associated with managing these changes effectively.MethodsThe authors participated in two primary care consensus panels held on 28 November 2023 and on 21 May 2024. The focus for these expert panels was to understand the unmet needs within primary care to manage adults with T2D treated with non-intensive insulin therapy and incorporating the use of CGM systems. A Delphi Survey was undertaken among a wider group of Primary Care Diabetes Technology Network members in the United Kingdom, to understand prevalent attitudes to management of adults with T2D on insulin and using CGM in primary care. Based on these activities, a series of consensus statements were tested in a second Delphi Survey.ResultsThe activities described, involving primary care healthcare professionals (HCPs) with expertise in diabetes management, identified a series of training and educational needs within UK general practice that are central to skills development for the care of adults with T2D on insulin therapy and the application of CGM technology. Potential barriers to effective primary care management of people with T2D using CGM devices were identified. Areas of concern included confidence in national and local guidelines for the management of T2D using CGM systems, lack of experience on the part both of HCPs and people with T2D, clinical workflows and systems, as well as inbuilt resistance to change among primary care teams. However, the expert group were clear that the goal of providing care for people with T2D on non-intensive insulin therapy using CGM technology as standard of care could be met (94.3%, n = 33). This will deliver clinical benefits for people with T2D, and improvements to clinical workflows in primary care. Cost-savings to the health service were also identified as an outcome.ConclusionsThe need to adapt to the management of people with T2D on insulin therapy puts significant pressure on current workflows and skills for primary care teams. Steps in overcoming these immediate pressures, to ensure effective clinical management of people with T2D, are discussed, along with a series of consensus statements that identify the key areas of change to manage. Ultimately, the great majority of expert primary care HCPs were confident or very confident that using CGM technology will become the standard of care for people with T2D treated with insulin in primary care. Journal Article Diabetic Medicine 42 3 Wiley 0742-3071 1464-5491 continuous blood glucose monitoring; primary care; type 2 diabetes 1 3 2025 2025-03-01 10.1111/dme.15500 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Another institution paid the OA fee 2025-05-12T13:52:38.9283080 2025-04-10T12:37:00.1034183 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Biomedical Science Samuel Seidu 1 Lorraine Avery 2 Heather Bell 3 Pam Brown 4 Jane Diggle 5 Su Down 6 Ritesh Dua 7 Patrick Holmes 0000-0002-6401-663x 8 Rahul Mohan 9 Nicola Milne 10 Thinzar Min 0000-0003-4467-3840 11 James Ridgeway 12 Waqas Tahir 13 Sanjay Tanna 14 69258__34250__0d5e938e5b6348bc9038d26c2d5b4804.pdf 69258.VoR.pdf 2025-05-12T13:49:38.9354913 Output 267711 application/pdf Version of Record true © 2024 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License. true eng http://creativecommons.org/licenses/by/4.0/
title Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus
spellingShingle Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus
Thinzar Min
title_short Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus
title_full Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus
title_fullStr Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus
title_full_unstemmed Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus
title_sort Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus
author_id_str_mv 27cba511a4800fefddb6885ffffdb8b2
author_id_fullname_str_mv 27cba511a4800fefddb6885ffffdb8b2_***_Thinzar Min
author Thinzar Min
author2 Samuel Seidu
Lorraine Avery
Heather Bell
Pam Brown
Jane Diggle
Su Down
Ritesh Dua
Patrick Holmes
Rahul Mohan
Nicola Milne
Thinzar Min
James Ridgeway
Waqas Tahir
Sanjay Tanna
format Journal article
container_title Diabetic Medicine
container_volume 42
container_issue 3
publishDate 2025
institution Swansea University
issn 0742-3071
1464-5491
doi_str_mv 10.1111/dme.15500
publisher Wiley
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Biomedical Science{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Biomedical Science
document_store_str 1
active_str 0
description AimsThis expert consensus reviews the reality of primary care clinical management of people with type 2 diabetes (T2D) on non-intensive insulin therapy, with an emphasis on the use of continuous glucose monitoring (CGM) technology for effective care in this participant group. Here, we identify key unmet needs for skills and systems development within this frontline healthcare setting, along with major challenges and opportunities associated with managing these changes effectively.MethodsThe authors participated in two primary care consensus panels held on 28 November 2023 and on 21 May 2024. The focus for these expert panels was to understand the unmet needs within primary care to manage adults with T2D treated with non-intensive insulin therapy and incorporating the use of CGM systems. A Delphi Survey was undertaken among a wider group of Primary Care Diabetes Technology Network members in the United Kingdom, to understand prevalent attitudes to management of adults with T2D on insulin and using CGM in primary care. Based on these activities, a series of consensus statements were tested in a second Delphi Survey.ResultsThe activities described, involving primary care healthcare professionals (HCPs) with expertise in diabetes management, identified a series of training and educational needs within UK general practice that are central to skills development for the care of adults with T2D on insulin therapy and the application of CGM technology. Potential barriers to effective primary care management of people with T2D using CGM devices were identified. Areas of concern included confidence in national and local guidelines for the management of T2D using CGM systems, lack of experience on the part both of HCPs and people with T2D, clinical workflows and systems, as well as inbuilt resistance to change among primary care teams. However, the expert group were clear that the goal of providing care for people with T2D on non-intensive insulin therapy using CGM technology as standard of care could be met (94.3%, n = 33). This will deliver clinical benefits for people with T2D, and improvements to clinical workflows in primary care. Cost-savings to the health service were also identified as an outcome.ConclusionsThe need to adapt to the management of people with T2D on insulin therapy puts significant pressure on current workflows and skills for primary care teams. Steps in overcoming these immediate pressures, to ensure effective clinical management of people with T2D, are discussed, along with a series of consensus statements that identify the key areas of change to manage. Ultimately, the great majority of expert primary care HCPs were confident or very confident that using CGM technology will become the standard of care for people with T2D treated with insulin in primary care.
published_date 2025-03-01T05:29:01Z
_version_ 1856986721265123328
score 11.096295

Similar Items